NCT01907009 2023-04-19
MEL-CAP
Barts & The London NHS Trust
Phase 2/3 Terminated
Clinical Trials
11 trialsNCT01438112 2021-04-14
BOND
CG Oncology, Inc.
Phase 2/3 Terminated
NCT01902823 2019-12-13
Effect of Cancer Nurse Navigators on Patient Outcomes
University of Wisconsin, Madison
Phase 2/3 Terminated
NCT01475266 2017-03-29
Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)
Nippon Kayaku Co., Ltd.
Phase 2/3 Terminated
NCT01981707 2016-04-28
PRECHOL
University Hospital, Grenoble
Phase 2/3 Terminated
NCT01603420 2016-03-14
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
Proton Collaborative Group
Phase 2/3 Terminated
NCT00381836 2015-12-04
Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer
University of Aarhus
Phase 2/3 Terminated
NCT00332280 2013-03-20
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
Auron Healthcare GmbH
Phase 2/3 Terminated
NCT00127387 2012-06-26
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
The University of Texas Health Science Center at San Antonio
Phase 2/3 Terminated
NCT00312442 2010-06-02
Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy
STEBA France
Phase 2/3 Terminated
NCT00221728 2010-05-28
Comparison Between Surgery and Radiofrequency for Treatment of Renal Tumors
University Hospital, Bordeaux
Phase 2/3 Terminated